First Look Analyst Calls Briefing for Wednesday, November 2, 2022
Here is an early look at Wednesday's analyst research calls.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Red Electrica (RDEIY) upgraded to Hold from Sell at Berenberg
Downgrades:
> Abiomed (ABMD) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $388
> Bally’s Corporation (BALY) downgraded to Hold from Buy at Stifel; tgt lowered to $25
> British American Tobacco (BTI) downgraded to Neutral from Buy at Goldman
> Cleveland-Cliffs (CLF) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $12
> Ecolab (ECL) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $135
> NASDAQ (NDAQ) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $57
> Semler Scientific (SMLR) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $45
> Universal Logistics (ULH) downgraded to Hold from Buy at Stifel; tgt $36
Others:
> Aeva (AEVA) initiated with a Hold at WestPark Capital; tgt $3
> AEye (LIDR) initiated with a Hold at WestPark Capital; tgt $1
> Canopy Growth (CGC) initiated with an Underperform at Bernstein; tgt $1.50
> Check Point Software (CHKP) initiated with a Neutral at Macquarie; tgt $129
> Cloudflare (NET) initiated with a Neutral at Macquarie; tgt $60
> CrowdStrike (CRWD) initiated with an Outperform at Macquarie; tgt $220
> Datadog (DDOG) initiated with a Neutral at Macquarie; tgt $85
> Dynatrace (DT) initiated with a Neutral at Macquarie; tgt $38
> HubSpot (HUBS) initiated with an Outperform at Macquarie; tgt $355
> Innoviz Technologies (INVZ) initiated with a Buy at WestPark Capital; tgt $12
> Legend Biotech (LEGN) initiated with an Outperform at Evercore ISI
> Lineage Cell Therapeutics (LCTX) initiated with an Outperform at Robert W. Baird; tgt $5
> Luminar Technologies (LAZR) initiated with a Buy at WestPark Capital; tgt $14
> Microsoft (MSFT) initiated with a Neutral at Macquarie; tgt $234
> nCino (NCNO) assumed with an Outperform at Macquarie; tgt $42
> Okta (OKTA) initiated with a Neutral at Macquarie; tgt $60
> Ouster (OUST) initiated with a Buy at WestPark Capital; tgt $4
> Palo Alto Networks (PANW) initiated with a Neutral at Macquarie; tgt $185
> Salesforce (CRM) assumed with an Outperform at Macquarie; tgt $210
> ServiceNow (NOW) assumed with an Outperform at Macquarie; tgt $500
> Snowflake (SNOW) initiated with a Neutral at Macquarie; tgt $173
> Sorrento Therapeutics (SRNE) initiated with an Overweight at Cantor Fitzgerald; tgt $5
> Velodyne Lidar (VLDR) initiated with an Underperform at WestPark Capital
> Workday (WDAY) initiated with a Neutral at Macquarie; tgt $170
> Zscaler (ZS) initiated with a Neutral at Macquarie; tgt $155
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.